Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip)

被引:6
作者
Rau, Beate [1 ,2 ,3 ,4 ]
Feldbruegge, Linda [1 ,2 ,3 ,4 ]
Gronau, Felix [1 ,2 ,3 ,4 ]
Vilchez, Miguel Enrique Alberto [1 ,2 ,3 ,4 ]
Thuss-Patience, Peter [5 ,6 ,7 ,8 ]
Bonnot, Pierre Emmanuel [9 ,10 ]
Glehen, Olivier [10 ]
机构
[1] Charite, Dept Surg, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Charite, Chirurg Klin Campus Charite Mitte Campus Vircho, Berlin Inst Hlth, Berlin, Germany
[5] Charite, Med Klin Schwerpunkt Hamatol, Onkol & Tumour Immunol Campus Virchow Klin, Berlin, Germany
[6] Free Univ Berlin, Berlin, Germany
[7] Humboldt Univ, Berlin, Germany
[8] Charite, Berlin Inst Hlth, Berlin, Germany
[9] Hop Prive Jean Mermoz, Dept Gen, Visceral & oncol Surg, Lyon, France
[10] Hosp Civils Lyon, Dept Surg Oncol, CHU Lyon Sud, Lyon, France
关键词
Peritoneal metastasis; Gastric cancer; Prophylactic hyperthermic intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy; Peritonectomy; PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; STAGING LAPAROSCOPY; PERIOPERATIVE CHEMOTHERAPY; LAVAGE CYTOLOGY; OPEN-LABEL; MULTICENTER; ADENOCARCINOMA; HIPEC; RECURRENCE;
D O I
10.1159/000522604
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Gastric cancer (GC) is associated with a poor prognosis mostly due to peritoneal metastasis, which will develop in time during the patient's disease history. To prevent and treat peritoneal metastasis, different kinds of treatment regimens have been described. Summary: In this review, we addressed two main topics - prophylaxis and treatment of peritoneal metastasis in GC. Prevention should be directed towards diminishing cancer cell spillage and reducing adherence of cancer cells to the abdominal cavity. Postoperative washing of the abdomen with or without chemotherapy and additional heat are herein discussed. Key Messages: Treatment of existing peritoneal metastasis is effective in patients with limited disease and tumour spread. Cytoreductive surgery including resection of peritoneal metastasis followed directly with hyperthermic intraperitoneal chemotherapy can increase overall survival and progression-free survival in selected patients. Drugs, duration and time schedules of intraperitoneal chemotherapy are reviewed and presented. Intraperitoneal chemotherapy seems to improve the prognosis of patients with GC and peritoneal metastasis after complete resection of both primary and metastatic tumours.
引用
收藏
页码:81 / 89
页数:9
相关论文
共 78 条
[1]   Gastric Cancer, Version 3.2016 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Almhanna, Khaldoun ;
Bentrem, David J. ;
Chao, Joseph ;
Das, Prajnan ;
Denlinger, Crystal S. ;
Fanta, Paul ;
Farjah, Farhood ;
Fuchs, Charles S. ;
Gerdes, Hans ;
Gibson, Michael ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Jaroszewski, Dawn ;
Johung, Kimberly L. ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Korn, W. Michael ;
Leong, Stephen ;
Linn, Catherine ;
Lockhart, A. Craig ;
Ly, Quan P. ;
Mulcahy, Mary F. ;
Orringer, Mark B. ;
Perry, Kyle A. ;
Poultsides, George A. ;
Scott, Walter J. ;
Strong, Vivian E. ;
Washington, Mary Kay ;
Weksler, Benny ;
Willett, Christopher G. ;
Wright, Cameron D. ;
Zelman, Debra ;
McMillian, Nicole ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10) :1286-1312
[2]   Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma [J].
Al-Batran, S. -E. ;
Van Cutsem, E. ;
Oh, S. C. ;
Bodoky, G. ;
Shimada, Y. ;
Hironaka, S. ;
Sugimoto, N. ;
Lipatov, O. N. ;
Kim, T. -Y. ;
Cunningham, D. ;
Rougier, P. ;
Muro, K. ;
Liepa, A. M. ;
Chandrawansa, K. ;
Emig, M. ;
Ohtsu, A. ;
Wilke, H. .
ANNALS OF ONCOLOGY, 2016, 27 (04) :673-679
[3]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[4]   Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer The AIO-FLOT3 Trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Illerhaus, Gerald ;
Martens, Uwe M. ;
Stoehlmacher, Jan ;
Schmalenberg, Harald ;
Luley, Kim B. ;
Prasnikar, Nicole ;
Egger, Matthias ;
Probst, Stephan ;
Messmann, Helmut ;
Moehler, Markus ;
Fischbach, Wolfgang ;
Hartmann, Joerg T. ;
Mayer, Frank ;
Hoeffkes, Heinz-Gert ;
Koenigsmann, Michael ;
Arnold, Dirk ;
Kraus, Thomas W. ;
Grimm, Kersten ;
Berkhoff, Stefan ;
Post, Stefan ;
Jager, Elke ;
Bechstein, Wolf ;
Ronellenfitsch, Ulrich ;
Moenig, Stefan ;
Hofheinz, Ralf D. .
JAMA ONCOLOGY, 2017, 3 (09) :1237-1244
[5]   Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Hofheinz, Ralf D. ;
Pauligk, Claudia ;
Kopp, Hans-Georg ;
Haag, Georg Martin ;
Luley, Kim Barbara ;
Meiler, Johannes ;
Homann, Nils ;
Lorenzen, Sylvie ;
Schmalenberg, Harald ;
Probst, Stephan ;
Koenigsmann, Michael ;
Egger, Matthias ;
Prasnikar, Nicole ;
Caca, Karel ;
Trojan, Joerg ;
Martens, Uwe M. ;
Block, Andreas ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Clemens, Michael ;
Illerhaus, Gerald ;
Zirlik, Katja ;
Behringer, Dirk M. ;
Schmiegel, Wolff ;
Pohl, Michael ;
Heike, Michael ;
Ronellenfitsch, Ulrich ;
Schuler, Martin ;
Bechstein, Wolf O. ;
Koenigsrainer, Alfred ;
Gaiser, Timo ;
Schirmacher, Peter ;
Hozaeel, Wael ;
Reichart, Alexander ;
Goetze, Thorsten O. ;
Sievert, Mark ;
Jaeger, Elke ;
Moenig, Stefan ;
Tannapfel, Andrea .
LANCET ONCOLOGY, 2016, 17 (12) :1697-1708
[6]  
[Anonymous], 2018, CA Cancer J Clin, DOI DOI 10.3322/caac.20115
[7]   A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology [J].
Badgwell, Brian ;
Ikoma, Naruhiko ;
Murphy, Mariela Blum ;
Wang, Xuemei ;
Estrella, Jeannelyn ;
Roy-Chowdhuri, Sinchita ;
Das, Prajnan ;
Minsky, Bruce D. ;
Lano, Elizabeth ;
Song, Shumei ;
Mansfield, Paul ;
Ajani, Jaffer .
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) :258-264
[8]   Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma [J].
Badgwell, Brian ;
Blum, Mariela ;
Das, Prajnan ;
Estrella, Jeannelyn ;
Wang, Xuemei ;
Ho, Linus ;
Fournier, Keith ;
Royal, Richard ;
Mansfield, Paul ;
Ajani, Jaffer .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) :3338-3344
[9]   Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial [J].
Beeharry, Maneesh Kumarsing ;
Ni, Zhen-Tian ;
Yang, Zhong Yin ;
Zheng, Ya Nan ;
Feng, Run Hua ;
Liu, Wen-Tao ;
Yan, Chao ;
Yao, Xue Xin ;
Li, Chen ;
Yan, Min ;
Zhu, Zheng-Gang .
BMC CANCER, 2020, 20 (01)
[10]   The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection [J].
Bentrem, D ;
Wilton, A ;
Mazumdar, M ;
Brennan, M ;
Coit, D .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (05) :347-353